XLV Holdings Information

XLV is an equity ETF with a total of 63 individual holdings. The top holdings are Eli Lilly and Company stock at 14.34%, Johnson & Johnson at 10.59%, AbbVie at 7.24%, Merck & Co. at 5.24%, and UnitedHealth Group at 4.61%.

Total Holdings

Top 10 Percentage

58.96%

Asset Class

Equity

ETF Category

Health

Assets

40.32B

PE Ratio

24.21

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	14.34%	5,754,945
2	JNJ	Johnson & Johnson	10.59%	17,459,977
3	ABBV	AbbVie Inc.	7.24%	12,808,130
4	MRK	Merck & Co., Inc.	5.24%	17,986,987
5	UNH	UnitedHealth Group Incorporated	4.61%	6,564,551
6	AMGN	Amgen Inc.	3.65%	3,902,284
7	ABT	Abbott Laboratories	3.47%	12,601,410
8	TMO	Thermo Fisher Scientific Inc.	3.39%	2,722,726
9	GILD	Gilead Sciences, Inc.	3.32%	8,991,041
10	ISRG	Intuitive Surgical, Inc.	3.11%	2,568,998
11	PFE	Pfizer Inc.	2.79%	41,203,888
12	VRTX	Vertex Pharmaceuticals Incorporated	2.28%	1,838,715
13	SYK	Stryker Corporation	2.23%	2,494,226
14	DHR	Danaher Corporation	2.21%	4,555,807
15	BMY	Bristol-Myers Squibb Company	2.21%	14,752,883
16	MDT	Medtronic plc	2.08%	9,294,994
17	MCK	McKesson Corporation	2.07%	894,467
18	BSX	Boston Scientific Corporation	1.87%	10,743,193
19	CVS	CVS Health Corporation	1.75%	9,199,440
20	HCA	HCA Healthcare, Inc.	1.55%	1,157,618
21	REGN	Regeneron Pharmaceuticals, Inc.	1.40%	730,321
22	CI	The Cigna Group	1.26%	1,935,833
23	COR	Cencora, Inc.	1.23%	1,405,053
24	ELV	Elevance Health, Inc.	1.13%	1,610,531
25	ZTS	Zoetis Inc.	0.96%	3,193,644

Showing 25 of 63 holdings

Subscribe to see the full list

Activate Now

As of Mar 10, 2026